RT Journal Article
SR Electronic
T1 Development and validation of the MMCD score to predict kidney replacement therapy in COVID-19 patients
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.01.11.22268631
DO 10.1101/2022.01.11.22268631
A1 Figueiredo, Flávio de Azevedo
A1 Ramos, Lucas Emanuel Ferreira
A1 Silva, Rafael Tavares
A1 Pires, Magda Carvalho
A1 Ponce, Daniela
A1 de Carvalho, Rafael Lima Rodrigues
A1 Schwarzbold, Alexandre Vargas
A1 Maurílio, Amanda de Oliveira
A1 Alves Scotton, Ana Luiza Bahia
A1 Garbini, Andresa Fontoura
A1 Farace, Bárbara Lopes
A1 Garcia, Bárbara Machado
A1 da Silva, Carla Thais Cândida Alves
A1 Cimini, Christiane Corrêa Rodrigues
A1 de Carvalho, Cíntia Alcantara
A1 Dias, Cristiane dos Santos
A1 Silveira, Daniel Vitorio
A1 Manenti, Euler Roberto Fernandes
A1 de Almeida Cenci, Evelin Paola
A1 Anschau, Fernando
A1 Aranha, Fernando Graça
A1 de Aguiar, Filipe Carrilho
A1 Bartolazzi, Frederico
A1 Vietta, Giovanna Grunewald
A1 Nascimento, Guilherme Fagundes
A1 Noal, Helena Carolina
A1 Duani, Helena
A1 Vianna, Heloisa Reniers
A1 Guimarães, Henrique Cerqueira
A1 de Alvarenga, Joice Coutinho
A1 Chatkin, José Miguel
A1 de Moraes, Júlia Parreiras Drumond
A1 Rugolo, Juliana Machado
A1 Ruschel, Karen Brasil
A1 Prado Martins, Karina Paula Medeiros
A1 Menezes, Luanna Silva Monteiro
A1 Couto, Luciana Siuves Ferreira
A1 de Castro, Luís César
A1 Nasi, Luiz Antônio
A1 Cabral, Máderson Alvares de Souza
A1 Floriani, Maiara Anschau
A1 Souza, Maíra Dias
A1 Souza e Silva, Maira Viana Rego
A1 Carneiro, Marcelo
A1 de Godoy, Mariana Frizzo
A1 Bicalho, Maria Aparecida Camargos
A1 Barbosa Lima, Maria Clara Pontello
A1 Nogueira, Matheus Carvalho Alves
A1 Martins, Matheus Fernandes Lopes
A1 Guimarães-Júnior, Milton Henriques
A1 Sampaio, Natália da Cunha Severino
A1 de Oliveira, Neimy Ramos
A1 Ziegelmann, Patricia Klarmann
A1 Andrade, Pedro Guido Soares
A1 Assaf, Pedro Ledic
A1 de Lima Martelli, Petrônio José
A1 Pereira, Polianna Delfino
A1 Martins, Raphael Castro
A1 Menezes, Rochele Mosmann
A1 Francisco, Saionara Cristina
A1 Araújo, Silvia Ferreira
A1 Oliveira, Talita Fischer
A1 de Oliveira, Thainara Conceição
A1 Sales, Thaís Lorenna Souza
A1 Ramires, Yuri Carlotto
A1 Marcolino, Milena Soriano
YR 2022
UL http://medrxiv.org/content/early/2022/01/13/2022.01.11.22268631.abstract
AB Background Acute kidney injury (AKI) is frequently associated with COVID-19 and the need for kidney replacement therapy (KRT) is considered an indicator of disease severity. This study aimed to develop a prognostic score for predicting the need for KRT in hospitalized COVID-19 patients.Methods This study is part of the multicentre cohort, the Brazilian COVID-19 Registry. A total of 5,212 adult COVID-19 patients were included between March/2020 and September/2020. We evaluated four categories of predictor variables: (1) demographic data; (2) comorbidities and conditions at admission; (3) laboratory exams within 24 h; and (4) the need for mechanical ventilation at any time during hospitalization. Variable selection was performed using generalized additive models (GAM) and least absolute shrinkage and selection operator (LASSO) regression was used for score derivation. The accuracy was assessed using the area under the receiver operating characteristic curve (AUC-ROC). Risk groups were proposed based on predicted probabilities: non-high (up to 14.9%), high (15.0 – 49.9%), and very high risk (≥ 50.0%).Results The median age of the model-derivation cohort was 59 (IQR 47-70) years, 54.5% were men, 34.3% required ICU admission, 20.9% evolved with AKI, 9.3% required KRT, and 15.1% died during hospitalization. The validation cohort had similar age, sex, ICU admission, AKI, required KRT distribution and in-hospital mortality. Thirty-two variables were tested and four important predictors of the need for KRT during hospitalization were identified using GAM: need for mechanical ventilation, male gender, higher creatinine at admission, and diabetes. The MMCD score had excellent discrimination in derivation (AUROC = 0.929; 95% CI 0.918–0.939) and validation (AUROC = 0.927; 95% CI 0.911–0.941) cohorts an good overall performance in both cohorts (Brier score: 0.057 and 0.056, respectively). The score is implemented in a freely available online risk calculator (https://www.mmcdscore.com/).Conclusion The use of the MMCD score to predict the need for KRT may assist healthcare workers in identifying hospitalized COVID-19 patients who may require more intensive monitoring, and can be useful for resource allocation.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported in part by Minas Gerais State Agency for Research and Development (Fundação de Amparo à Pesquisa do Estado de Minas Gerais –FAPEMIG) [grant number APQ–00208–20] and National Institute of Science and Technology for Health Technology Assessment (Instituto de Avaliação de Tecnologias em Saúde–IATS)/ National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Científico e Tecnológico –CNPq) [grant number 465518/2014–1].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by Brazilian National Committee for Ethics in Research - CONEP (CAAE - Certificate of presentation of Ethical Appreciation: 30350820.5.1001.0008)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authorsAKIacute kidney injuryARDSacute respiratory distress syndromeAUROCarea under the receiver operating characteristicBMIbody mass indexBPM1beats per minuteBPM2breaths per minuteCIconfidence intervalCOPDchronic obstructive pulmonary diseaseCOVID-19Coronavirus disease 19GAMgeneralized additive modelsGBTgradient boosted treesICUintensive care unitIL-6interleukin-6IQRinterquartile rangeKDIGOKidney Disease Improving Global OutcomesKRTkidney replacement therapyLASSOleast absolute shrinkage and selection operatorMICEmultiple imputation with chained equationsMMCDmechanical ventilation, male, creatinine, diabetesMVmechanical ventilationpCO2partial pressure of carbon dioxidePEEPpositive end-expiratory pressurePMMPredictive mean matchingPO2partial pressure of oxygenPROBASTPrediction model Risk Of Bias Assessment ToolREDCapResearch Electronic Data CaptureSBPsystolic blood pressureSF ratioSpO2/FiO2 ratioSOFASepsis-related Organ Failure AssessmentTRIPODTransparent Reporting of a Multivariable Prediction Model for Individual Prediction or DiagnosisUSAUnited States of America